BridgeBio Oncology Therapeutics (BBOT) Insider Trading & Ownership

BridgeBio Oncology Therapeutics logo
$1.81 -0.05 (-2.69%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$1.94 +0.14 (+7.46%)
As of 11/20/2026 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$3.63K
Get BBOT Insider Trade Alerts

Want to know when executives and insiders are buying or selling BridgeBio Oncology Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBOT Insider Buying and Selling by Quarter

BridgeBio Oncology Therapeutics Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2026
Pedro Beltran
CEO
Sell1,870$1.84$3,440.80  
11/13/2026
Marc Cobo
Insider
Sell78$2.37$184.86  
(Data available from 1/1/2013 forward)

BBOT Insider Trading Activity - Frequently Asked Questions

The list of insiders at BridgeBio Oncology Therapeutics includes Marc Cobo, and Pedro Beltran. Learn more on insiders at BBOT.

24.40% of BridgeBio Oncology Therapeutics stock is owned by insiders. Learn more on BBOT's insider holdings.

The following insiders have sold BBOT shares in the last 24 months: Marc Cobo ($184.86), and Pedro Beltran ($3,440.80).

Insiders have sold a total of 1,948 BridgeBio Oncology Therapeutics shares in the last 24 months for a total of $3,625.66 sold.



Insider trading data for NASDAQ:BBOT was last updated on 11/18/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners